Trial Profile
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 Jun 2009 New trial record